Therapeutic Asset Ratings
1,055 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
PIMURUTAMAB
Non-Small Cell Squamous Lung Carcinoma
Shanghai Henlius Biotech
P2/3
B
(57)
Posaconazole
Aspergillosis
Bambino Gesù Hospital and Research Institute
P2/3
B
(57)
Posiphen
Alzheimer Disease
Annovis Bio Inc.
P2/3
B
(57)
PREDNISONE TABLETS
Primary Biliary Cholangitis
Han Ying
P2/3
B
(57)
PROPOFOL
Acquired Aneurysmal Subarachnoid Hemorrhage
Jenna L Leclerc MD, PhD
P2/3
B
(57)
Ramatroban
COVID-19
KARE Biosciences
P2/3
B
(57)
Rasagiline
REM Sleep Behavior Disorder
Second Affiliated Hospital, School of Medicine, Zhejiang University
P2/3
B
(57)
Rasagiline
Synucleinopathy
Second Affiliated Hospital, School of Medicine, Zhejiang University
P2/3
B
(57)
rc148
Colorectal Cancer
RemeGen Co., Ltd.
P2/3
B
(57)
Recombinant Human Hyaluronidase
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)
P2/3
B
(57)
Recombinant Human Hyaluronidase
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
National Cancer Institute (NCI)
P2/3
B
(57)
Recombinant Human Hyaluronidase
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
National Cancer Institute (NCI)
P2/3
B
(57)
Recombinant Human Hyaluronidase
Intravascular Large B-Cell Lymphoma
National Cancer Institute (NCI)
P2/3
B
(57)
Recombinant Human Hyaluronidase
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
National Cancer Institute (NCI)
P2/3
B
(57)
Recombinant Human Tissue Kallikrein
Ischemic Stroke
DiaMedica Therapeutics Inc
P2/3
B
(57)
Relatlimab
Infiltrating Bladder Urothelial Carcinoma
National Cancer Institute (NCI)
P2/3
B
(57)
Remternetug
Familial Alzheimer Disease
Washington University School of Medicine
P2/3
B
(57)
RG6289
Early-Onset Autosomal Dominant Alzheimer Disease
Banner Health
P2/3
B
(57)
RG6289
Alzheimer Disease
Banner Health
P2/3
B
(57)
Rifaximin
Small Intestine Disorder
Wake Forest University Health Sciences
P2/3
B
(57)
Rosuvastatin
Cirrhosis Of Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
P2/3
B
(57)
Rosuvastatin
Peripheral Neuropathy
Tanta University
P2/3
B
(57)
sc1011
Idiopathic Pulmonary Fibrosis
Guangzhou JOYO Pharma Co., Ltd
P2/3
B
(57)
Semaglutide
Systolic Heart Failure
Jens D Hove, MD,PHD
P2/3
B
(57)
Silymarin
Peripheral Neuropathy
Tanta University
P2/3
B
(57)
Showing 601 to 625 of 1,055 assets
Previous
Page 25 of 43
Next